Behavioral Interventions for Chronic Insomnia
(IBI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two different behavioral approaches to assist people with chronic insomnia who regularly use sleeping pills. The aim is to improve sleep habits and potentially reduce or stabilize the need for these medications. Participants will be divided into two groups, each receiving a different but clinically proven behavioral treatment. This trial suits individuals aged 55 to 85 who take sleeping pills at least three times a week and have a diagnosis of chronic insomnia. As an unphased trial, it offers an opportunity to explore innovative treatments that could enhance quality of life.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it aims to monitor and decrease sleeping pill usage. It might be possible that you will be asked to reduce your sleeping pill intake during the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that both methods being tested are safe for treating insomnia. Studies have found that Cognitive Behavioral Therapy for Insomnia (CBT-I), included in both methods, is very effective and safe. It often works as well as sleep medications but without side effects.
CBT-I improves sleep by changing poor sleep habits and correcting misconceptions about sleep. It has been shown to enhance sleep over time. Participants using CBT-I report fewer sleep problems and better sleep quality. Therefore, those considering joining this study can be assured that the treatments involved are well-tolerated and safe according to previous research.12345Why are researchers excited about this trial?
Researchers are excited about these behavioral interventions for chronic insomnia because they focus on non-pharmacological approaches, which can reduce reliance on medications. Unlike standard treatments that often involve prescription sleep aids, these approaches emphasize sleep hygiene and cognitive strategies to improve sleep quality naturally. By potentially reducing the side effects associated with medication use, these methods offer a promising alternative for individuals seeking long-term, sustainable solutions to insomnia.
What evidence suggests that this trial's behavioral interventions could be effective for chronic insomnia?
Research has shown that Cognitive Behavioral Therapy for Insomnia (CBT-I), included in both behavioral approaches in this trial, effectively treats long-term insomnia. Participants will receive either Behavioral Approach 1 or Behavioral Approach 2, both incorporating CBT-I. Studies have found that CBT-I can be as effective as sleep medications, but without side effects. Those who undergo CBT-I often experience better sleep and fewer recurrences of insomnia. This therapy aids in falling asleep and staying asleep, leading to improved overall sleep. Additionally, online versions of CBT-I have greatly improved sleep patterns and quality. Overall, strong evidence supports CBT-I as a successful treatment for insomnia.15678
Are You a Good Fit for This Trial?
This trial is for adults aged 55-85 who have been diagnosed with chronic insomnia and regularly use sleeping pills at least three nights a week. Participants must be able to speak English, use a smartphone or tablet, and have internet access. Those with acute medical conditions or severe mental health issues like major depression or psychosis are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a behavioral intervention including sleep hygiene improvements and coaching support
Follow-up
Participants are monitored for changes in sleep pill dosage and sleep efficiency
What Are the Treatments Tested in This Trial?
Interventions
- Behavioral approach 1
- Behavioral approach 2
Behavioral approach 1 is already approved in United States, European Union, Canada for the following indications:
- Chronic Insomnia Disorder
- Insomnia
- Sleep Disorders
- Insomnia
- Sleep Disturbances
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor